TY - JOUR
T1 - Joint surgery in von Willebrand disease: a multicentre cross-sectional study
AU - van Galen, K. P. M.
AU - Meijer, K.
AU - Vogely, H. C.
AU - Eikenboom, J.
AU - Schutgens, R. E. G.
AU - Cnossen, M. H.
AU - Fijnvandraat, K.
AU - van der Bom, J. G.
AU - Laros-van Gorkom, B. A. P.
AU - Leebeek, F. W. G.
AU - Mauser-Bunschoten, E. P.
PY - 2016
Y1 - 2016
N2 - Background: Joint bleeds are reported by 23% of von Willebrand disease (VWD) patients and associated with orthopaedic surgery. Limited data are available on joint surgery in VWD. Aim: To assess the prevalence, indications, management and complications of joint surgery in VWD patients. Methods: 804 VWD patients with historically lowest von Willebrand factor (VWF) activity <= 30 U dL(-1) completed a questionnaire on joint bleeds, joint damage and orthopaedic surgery. We retrieved additional medical file data of patients who underwent surgery on large joints (shoulder, elbow, hip, knee or ankle). Results: 116 out of 804 patients (14%) reported large joint surgery. Compared to VWD patients without previous orthopaedic surgery, these 116 patients reported more frequently a history of joint bleeds and joint damage (41% vs. 20%, P <0.001 and 61% vs. 20%, P <0.001). Medical file data on 126 large joint surgeries in 79 VWD patients revealed that this surgery was associated with joint damage due to prior joint bleeds in 24% of the procedures. Preoperative clotting factor correction (CFC) to prevent bleeding was administered in most cases (81%). Documentation on postoperative bleeding was found in 23 surgeries (18%). Conclusions: Large joint surgery is reported by 14% of VWD patients, related to joint bleeds in 24% and seems associated with bleeding complications frequently despite perioperative CFC
AB - Background: Joint bleeds are reported by 23% of von Willebrand disease (VWD) patients and associated with orthopaedic surgery. Limited data are available on joint surgery in VWD. Aim: To assess the prevalence, indications, management and complications of joint surgery in VWD patients. Methods: 804 VWD patients with historically lowest von Willebrand factor (VWF) activity <= 30 U dL(-1) completed a questionnaire on joint bleeds, joint damage and orthopaedic surgery. We retrieved additional medical file data of patients who underwent surgery on large joints (shoulder, elbow, hip, knee or ankle). Results: 116 out of 804 patients (14%) reported large joint surgery. Compared to VWD patients without previous orthopaedic surgery, these 116 patients reported more frequently a history of joint bleeds and joint damage (41% vs. 20%, P <0.001 and 61% vs. 20%, P <0.001). Medical file data on 126 large joint surgeries in 79 VWD patients revealed that this surgery was associated with joint damage due to prior joint bleeds in 24% of the procedures. Preoperative clotting factor correction (CFC) to prevent bleeding was administered in most cases (81%). Documentation on postoperative bleeding was found in 23 surgeries (18%). Conclusions: Large joint surgery is reported by 14% of VWD patients, related to joint bleeds in 24% and seems associated with bleeding complications frequently despite perioperative CFC
U2 - https://doi.org/10.1111/hae.12834
DO - https://doi.org/10.1111/hae.12834
M3 - Article
C2 - 26551280
SN - 1351-8216
VL - 22
SP - 256
EP - 262
JO - Haemophilia
JF - Haemophilia
IS - 2
ER -